Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Hormonal Contraceptives Market Through 2029?

Recently, there has been a slight expansion in the market size of hormonal contraceptives. This market is projected to rise from $14.28 billion in 2024 to $14.4 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 0.9%. The historic growth can be traced back to factors such as government initiatives, the widened usage of contraceptives, an increase in the expenditure on pharmaceutical research and development, a surge in healthcare spending, and a rise in the number of healthcare facilities.

In the coming years, the market size of hormonal contraceptives is projected to experience a slight expansion. The market is forecasted to reach “$15.46 billion in 2029, growing at a compound annual growth rate (CAGR) of 1.8%. Factors contributing to this growth during the forecast period include an increase in family planning awareness, an upsurge in research and development expenditure, a rise in healthcare spending, and augmenting partnerships between agencies. The forecast period is expected to observe trends such as investment in durable vaginal rings, adoption of AI to enhance medication compliance, the introduction of innovative products, focus on environmentally friendly estrogen profile, improvement in progestogen-only birth control pills, and continuing investment in long-lasting delivery drug systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Market Forces Are Driving The Hormonal Contraceptives Sector In 2025 And Beyond?

The heightened understanding of hormonal contraceptives is enhancing the knowledge and autonomy of the global populace, enabling them to make suitable reproductive and lifestyle decisions. This expanding knowledge on contraceptive options empowers individuals to make smarter choices concerning their reproductive well-being, which consequently leads to greater use of hormonal contraceptives that match their family planning needs and lifestyle choices. For example, the World Health Organization (WHO), a Switzerland-based UN agency focusing on global public health, revealed in September 2023 that the estimated worldwide use of any contraceptive method was 65% in 2022, and the use of modern contraceptive methods among married or partnered women stood at 58.7%. The satisfaction rate across the globe for employing modern family planning methods among women between 15–49 years is predicted to reach 77.5% in 2022. The increased consciousness about the benefits and proper use of contraceptives considerably fuels the hormonal contraceptives market.

The hormonal contraceptives market covered in this report is segmented –

1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones : Progestin-Only, Combined Hormones

4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What Long-Term Trends Are Likely To Affect The Hormonal Contraceptives Market?

Firms are pioneering the development of masticable, low-dose oral birth control to minimize side effects. This chewable contraceptive project was a move towards reducing adverse health effects and simultaneously facilitating patients’ assimilation into daily use of the contraceptive. The medicine is currently available for purchase without a prescription. Leading players in the creation and distribution of chewable, low-dose contraceptives are companies such as Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals.

Which Firms Are Considered Leaders In The Hormonal Contraceptives Market Space?

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

What Role Do Regional Policies And Investments Play In Hormonal Contraceptives Market Expansion?

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model